Skip to main content

Table 1 Patient characteristics (* pro-BNP was not measured routinely; abbreviations see text)

From: Contrast enhanced transesophageal echocardiography in patients with atrial fibrillation referred to electrical cardioversion improves atrial thrombus detection and may reduce associated thromboembolic events

  Contrast-enhanced TEE Control group p value
n 90 90  
Age 65.9±12 64.5±13 0.474
female, % 32.2 24.4 0.247
BMI, kg/m2 27.9±5.0 26.2±4.1 0.111
history of TIA/Stroke, % 4.8 2.7 0.522
COPD ≥ °II, % 4.8 8.2 0.433
diabetes mellitus, % 21.3 13.7 0.244
hypertension, % 58.7 60.3 0.855
CAD, % 27.7 28 0.968
previous.MI, % 4.8 6.8 0.606
hyperlipoproteinemia, % 20.6 20.3 0.958
heart rate 1/min 91.7±26 92.8±24 0.803
antiocoagulation ≥1 day (prior to TEE, %) 51 48 0.764
antiocoagulation ≥3w (prior to TEE, %) 13 11 0.544
hemoglobinn (g/dl) 14.2±1.7 14.3±1.7 0.834
pro-BNP (pg/ml) * 1817±1700* * *
creatinine (mg/dl) 1.1±0.49 1.1±0.28 0.728
potassium (mmol/l) 4.2±0.43 4.2±0.43 0.928
C-reactive protein (mg/dl) 1.1±2.1 1.5±2.9 0.377